Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEROPENEM ANHYDROUS vs METAXALONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MEROPENEM ANHYDROUS vs METAXALONE: Safety Overview

Metric MEROPENEM ANHYDROUS METAXALONE
Total FAERS Reports 144 1,452
Deaths Reported 25 464
Death Rate 17.4% 32.0%
Hospitalizations 102 175
Average Patient Age 55.0 yrs 53.2 yrs
% Female Patients 44.2% 80.6%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Mylan Institutional LLC Asclemed USA, Inc.
Route INTRAVENOUS ORAL
Marketing Status N/A Discontinued